1612184-57-2

Upstream product

• 80866-88-2 (3-methoxy-4-nitrophenyl)methanol 
• 1612184-56-1 tert-butyl 4-(((4-((tert-butyldimethylsilyloxy)methyl)-2-methoxyphenyl)(tert-butyloxycarbonyl)amino)methyl)phenylcarbamate 
• 1612184-55-0 tert-butyl 4-((4-((tert-butyldimethylsilyloxy)methyl)-2-methoxyphenylamino)methyl)phenylcarbamate 
• 882430-23-1 4-((tert-butyldimethylsilyloxy)methyl)-2-methoxyaniline 
• 882430-21-9 tert-butyl(3-methoxy-4-nitrobenzyloxy)dimethylsilane 

Downstream Products

• 1612184-49-2 (E)-2-(2-(4-(4-aminobenzylamino)-3-methoxystyryl)-6-methyl-4H-pyran-4-ylidene)malononitrile 
• 1612184-60-7 C₃₅H₃₈N₄O₆ 
• 1612184-54-9 tert-butyl 4-(((tert-butyloxycarbonyl)(4-formyl-2-methoxyphenyl)amino)methyl)phenylcarbamate 

Relevant academic research and scientific papers

METHODS OF DETECTING MYELIN BASIC PROTEIN

A method and a kit for detecting myelin basic protein are provided. The method comprises administering an agent, which binds to myelin basic protein (MBP), to a subject at risk of or diagnosed with a myelin-associated neuropathy, and determining myelination by detecting the agent resided in the subject. The amount of the agent present in the subject is indicative of a myelin-associated neuropathy. A method of quantifying an amount of MBP present in a tissue sample is also provided, wherein the method comprises contacting the tissue sample with the same agent, detecting the agent present in the tissue sample; and quantifying an amount of the agent present in the tissue sample.